The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 22, 2009, Pages 9021-9026

  Cayrol, Corinne ^a,b   Girard, Jean Philippe ^a,b  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Endothelial cell; Inflammation; Interleukin

Indexed keywords

ASPARTIC ACID; CASPASE 3; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 33; SERINE;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL MATURATION; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME SUBSTRATE; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; INFECTION; INJURY; INNATE IMMUNITY; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE INJURY;

CASPASE 1; CELL LINE; DNA MUTATIONAL ANALYSIS; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1; INTERLEUKINS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; SEQUENCE DELETION;

EID: 67049158193     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0812690106     Document Type: Article

References (36)

1. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87:2095-2147. (Pubitemid 26086851)
2. Dinarello CA (2000) Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 11:483-486.
3. Baekkevold ES, et al. (2003) Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 163:69-79. (Pubitemid 36759592)
4. Schmitz J, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479-490. (Pubitemid 41587888)
5. Carriere V, et al. (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 104:282-287. (Pubitemid 46068023)
6. Xu D, et al. (2008) IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 105:10913-10918.
7. Miller AM, et al. (2008) IL-33 reduces the development of atherosclerosis. J Exp Med 205:339-346. (Pubitemid 351281600)
8. Sanada S, et al. (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117:1538-1549. (Pubitemid 46871338)
9. Kakkar R, Lee RT (2008) The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7:827-840.
10. Allakhverdi Z, Smith DE, Comeau MR, DelespesseG(2007) Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179:2051-2054.
11. Ali S, et al. (2007) IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci USA 104:18660-18665. (Pubitemid 350210753)
12. Hayakawa H, Hayakawa M, Kume A, Tominaga S (2007) Soluble ST2 Blocks Interleukin- 33 Signaling in Allergic Airway Inflammation. J Biol Chem 282:26369-26380. (Pubitemid 47443815)
13. Ho LH, et al. (2007) IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J Leukoc Biol 82:1481-1490. (Pubitemid 350276960)
14. Chackerian AA, et al. (2007) IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex. J Immunol 179:2551-2555.
15. Moulin D, et al. (2007) Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40:216-225. (Pubitemid 350213434)
16. Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H (2008) A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 121:1484-1490. (Pubitemid 351787349)
17. Kondo Y, et al. (2008) Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol 20:791-800. (Pubitemid 351791523)
18. Smithgall MD, et al. (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 20:1019-1030.
19. Bourgeois E, et al. (2009) The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 39:1046-1055.
20. Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS ONE 3:e3331.
21. Kuchler AM, et al. (2008) Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol 173:1229-1242.
22. Roussel L, Erard M, Cayrol C, Girard JP (2008) Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep 9:1006-1012.
23. Werman A, et al. (2004) The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci USA 101:2434-2439. (Pubitemid 38269329)
24. Agresti A, BianchiME(2003)HMGBproteins and gene expression. Curr Opin Genet Dev 13:170-178.
25. Wang H, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251. (Pubitemid 29329996)
26. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195. (Pubitemid 34773774)
27. Chen CJ, et al. (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13:851-856. (Pubitemid 47038190)
28. Rao DA, Tracey KJ, Pober JS (2007) IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response. J Immunol 179:6536-6546.
29. Eigenbrod T, Park JH, Harder J, Iwakura Y, NunezG(2008) Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL- 1{alpha} released from dying cells. J Immunol 181:8194-8198.
30. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81:1-5. (Pubitemid 46028489)
31. Mosley B, et al. (1987) The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J Biol Chem 262:2941-2944. (Pubitemid 17127537)
32. Hudson CA, et al. (2008) Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 84:631-643.
33. McNeil, PL, Muthukrishnan L, Warder E, D'Amore PA (1989) Growth factors are released by mechanically wounded endothelial cells. J Cell Biol 109: 811-822 (Pubitemid 19197039)
34. Sharma S, et al. (2008) The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 180:5477-5482.
35. Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301-305. (Pubitemid 34303674)
36. Galli SJ, Nakae S, Tsai M (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6:135-142. (Pubitemid 40268194)